These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia. Vásquez Velásquez C; Russomando G; Espínola EE; Sanchez Z; Mochizuki K; Roca Y; Revollo J; Guzman A; Quiroga B; Rios Morgan S; Vargas Ortiz R; Zambrana Ortega A; Espinoza E; Nishizawa JE; Kamel MG; Kikuchi M; Mizukami S; Na-Bangchang K; Tien Huy N; Hirayama K PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007715. PubMed ID: 31553732 [TBL] [Abstract][Full Text] [Related]
29. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846 [TBL] [Abstract][Full Text] [Related]
30. The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection. Nguyen DM; Poveda C; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011519. PubMed ID: 37988389 [TBL] [Abstract][Full Text] [Related]
31. Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment. Aguilera E; Varela J; Serna E; Torres S; Yaluff G; Bilbao NV; Cerecetto H; Alvarez G; González M Mem Inst Oswaldo Cruz; 2018 Mar; 113(3):153-160. PubMed ID: 29412353 [TBL] [Abstract][Full Text] [Related]
32. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains. Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889 [TBL] [Abstract][Full Text] [Related]
33. Determination of Benznidazole in Human Dried Blood Spots by Liquid Chromatography-Mass Spectrometry to Monitor Adherence to Momper JD; Hanan NJ; Rossi SS; Mirochnick MH; Cafferata ML; Lavenia A; Flores I; Gibbons L; Ciganda A; Sosa Estani S; Capparelli EV; Buekens P Am J Trop Med Hyg; 2019 Jul; 101(1):116-122. PubMed ID: 31115303 [TBL] [Abstract][Full Text] [Related]
35. Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease. García-Bournissen F; Moroni S; Marson ME; Moscatelli G; Mastrantonio G; Bisio M; Cornou L; Ballering G; Altcheh J Arch Dis Child; 2015 Jan; 100(1):90-4. PubMed ID: 25210104 [TBL] [Abstract][Full Text] [Related]
36. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system. Fonseca-Berzal C; Palmeiro-Roldán R; Escario JA; Torrado S; Arán VJ; Torrado-Santiago S; Gómez-Barrio A Exp Parasitol; 2015 Feb; 149():84-91. PubMed ID: 25583295 [TBL] [Abstract][Full Text] [Related]
37. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease. Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982 [TBL] [Abstract][Full Text] [Related]
38. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients. García MC; Manzo RH; Jimenez-Kairuz AF Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402 [TBL] [Abstract][Full Text] [Related]
39. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S; J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946 [TBL] [Abstract][Full Text] [Related]
40. Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components? Morilla MJ; Prieto MJ; Romero EL Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):213-9. PubMed ID: 16021311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]